ADENOVIRUS REACTIVATION

This adverse event was reported 144 times

ADENOVIRUS REACTIVATION is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 ALLOGENIC THYMOCYTE-DEPLETED THYMUS TISSUE-AGDC 1 0.0345
1 TREOSULFAN 53 0.0192
2 CIDOFOVIR ANHYDROUS 18 0.0124
3 BRINCIDOFOVIR 1 0.0072
4 PROBENECID 5 0.0042
5 THIOTEPA 40 0.0041
6 FLUDARABINE PHOSPHATE 105 0.0026
7 FOSCARNET SODIUM 10 0.0025
8 MOSUNETUZUMAB 2 0.0018
9 ISRADIPINE 1 0.0018
See all drugs enriched for association with ADENOVIRUS REACTIVATION